StockTipsArenaBeta

BUY SYMBIOTEC PHARMALAB LTD — Motilal Oswal

BUYSYMBIOTEC PHARMALAB LTD
SYMBIOTEC PHARMALAB share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)7 Nov 2026via Moneycontrol Broker Research

Entry₹1,520Inferred
Target₹1,800
Total upside +18.42%
Stop lossNot given
CMP₹1,611.31d ago
Active+6.01%+11.71%upside left 12 mo left
Follow Motilal Oswal for new calls(59% target hit, 1213 closed calls)Get alertsWatch SYMBIOTEC for new buy/sell callsGet alertsSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:32 am IST
6 supporting5 neutral0 opposing
Supports the BUY call (6)

Symbiotec Pharmalabs shares surge 19% to a new post-listing high after 10-year deal with European protein innovator

NewsCnbc-Tv18·6 Nov · 1w ago

(opens in new tab)

Symbiotec Pharmalab has entered into a 10-year take-or-pay agreement to manufacture fermentation-based alternative protein for a European innovator.

BSE · Company Update·6 Nov · 1w ago

(opens in new tab)

Symbiotec Pharmalab Gets Motilal Oswal's 'Buy' Initiation; Check Target Price

NewsNdtv-Profit·26 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (5)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on SYMBIOTEC PHARMALAB

All analyst calls on SYMBIOTEC PHARMALAB

More from Motilal Oswal

Every call and its outcome